{"filing":{"accession_number":"0001437749-26-021134","cik":"0001595248","ticker":"GNPX","company_name":"Genprex, Inc.","form":"8-K","filing_date":"2026-06-18","report_date":null,"primary_document":"gnpx20260615_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1595248/000143774926021134/gnpx20260615_8k.htm"},"events":[{"id":11782,"run_id":10363,"accession_number":"0001437749-26-021134","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"Genprex held its 2026 Annual Meeting of Stockholders on June 18, 2026, with shareholders voting on five proposals: election of directors (Moreno Toscano and Confer), ratification of WithumSmith+Brown as auditor, advisory vote on named executive officer compensation, approval of the Amended 2018 Equity Incentive Plan (increasing authorized shares by 1,850,000), and approval of a reverse stock split amendment. All proposals received shareholder approval with detailed vote tallies disclosed.","company_name":"Genprex, Inc.","ticker":"GNPX","filing_date":"2026-06-18","form":"8-K","submitted_at":null,"items":[{"id":8455,"accession_number":"0001437749-26-021134","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure centers on stockholder approval of an amended and restated equity incentive plan that increases authorized shares by 1,850,000 for future equity awards to executives and employees. This is a compensatory arrangement amendment requiring shareholder approval under Item 5.02(e), distinct from executive departures or appointments. The material increase in share authorization directly affects the pool available for executive compensation grants.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-18T20:02:12.727292+00:00","company_name":"","ticker":null,"filing_date":""},{"id":8456,"accession_number":"0001437749-26-021134","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder voting results from Genprex's 2026 Annual Meeting held on June 18, 2026, covering five proposals: election of directors (Moreno Toscano and Confer), ratification of WithumSmith+Brown as auditor, advisory vote on NEO compensation, approval of the Amended 2018 Equity Incentive Plan, and approval of a reverse stock split amendment. The detailed vote tallies for each proposal are material to investors as they reflect stockholder approval of key governance and capital structure matters.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-18T20:02:12.727292+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":8455,"accession_number":"0001437749-26-021134","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure centers on stockholder approval of an amended and restated equity incentive plan that increases authorized shares by 1,850,000 for future equity awards to executives and employees. This is a compensatory arrangement amendment requiring shareholder approval under Item 5.02(e), distinct from executive departures or appointments. The material increase in share authorization directly affects the pool available for executive compensation grants.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-18T20:02:12.727292+00:00","company_name":"Genprex, Inc.","ticker":"GNPX","filing_date":"2026-06-18"},{"id":8456,"accession_number":"0001437749-26-021134","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder voting results from Genprex's 2026 Annual Meeting held on June 18, 2026, covering five proposals: election of directors (Moreno Toscano and Confer), ratification of WithumSmith+Brown as auditor, advisory vote on NEO compensation, approval of the Amended 2018 Equity Incentive Plan, and approval of a reverse stock split amendment. The detailed vote tallies for each proposal are material to investors as they reflect stockholder approval of key governance and capital structure matters.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-18T20:02:12.727292+00:00","company_name":"Genprex, Inc.","ticker":"GNPX","filing_date":"2026-06-18"}]}